Basma Adeem Medical Co. (SAU:9626) ROCE %: 21.44% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SAU:9626 Basma Adeem Medical Co. SAU:9626
21 GF Score
Price ﷼6.12
! 1 Warning Sign
View Full Analysis

What is Basma Adeem Medical Co. ROCE %?

Basma Adeem Medical Co. SAU:9626 21 ROCE % is 21.44% as of Dec. 2025. GuruFocus rates SAU:9626 with a GF Score™ of 21/100. The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Basma Adeem Medical Co.'s annualized ROCE % for the quarter that ended in Dec. 2025 was 21.44%.

Basma Adeem Medical Co.  (SAU:9626) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Basma Adeem Medical Co. ROCE % Related Terms

Basma Adeem Medical Co. ROCE % Historical Data

* Premium members only.

The historical data trend for Basma Adeem Medical Co.'s ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Basma Adeem Medical Co. ROCE % Chart

Basma Adeem Medical Co. Annual Data
Trend Dec24 Dec25
ROCE %
21.20 19.35

Basma Adeem Medical Co. Semi-Annual Data
Jun24 Dec24 Jun25 Dec25
ROCE % 0.00 26.62 14.35 21.44
SAU:9626
21GF Score
Basma Adeem Medical Co. SAU:9626
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Basma Adeem Medical Co. ROCE % Calculation

Basma Adeem Medical Co.'s annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=9.027/( ( (37.89 - 4.261) + (66.227 - 6.544) )/ 2 )
=9.027/( (33.629+59.683)/ 2 )
=9.027/46.656
=19.35 %

Basma Adeem Medical Co.'s ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=11.934/( ( (58.046 - 6.385) + (66.227 - 6.544) )/ 2 )
=11.934/( ( 51.661 + 59.683 )/ 2 )
=11.934/55.672
=21.44 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 21.44% mean?
Basma Adeem Medical Co. (SAU:9626) has a ROCE % of 21.44% as of Dec. 2025.
Is Basma Adeem Medical Co.'s ROCE % too high?
Basma Adeem Medical Co.'s current ROCE % is 21.44%. The Healthcare Providers & Services industry median ROCE % is 6.34. Basma Adeem Medical Co.'s value of 21.44% is 238.2% above this industry median. Overall, Basma Adeem Medical Co. has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Basma Adeem Medical Co.'s ROCE % compare to HCA and THC?
Basma Adeem Medical Co.'s ROCE % of 21.44% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.34. Basma Adeem Medical Co.'s value of 21.44% is 238.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.34, based on 642 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Basma Adeem Medical Co.'s current ROCE % of 21.44% is 238.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Basma Adeem Medical Co.'s current ROCE % is 21.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Basma Adeem Medical Co. stock overvalued right now?
Basma Adeem Medical Co. (SAU:9626) has a current ROCE % of 21.44%. The current ROCE % is 21.44% and 238.2% above the Healthcare Providers & Services industry median of 6.34. Basma Adeem Medical Co.'s overall GF Score™ is 21/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Basma Adeem Medical Co. (SAU:9626), the current ROCE % is 21.44% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Basma Adeem Medical Co. Business Description

Address King Abdulaziz Road, P.O. Box 13222, Al Yasmin District, Riyadh, SAU, 13322
Basma Adeem Medical Co. operates in the field of dental medicine, treatment, and cosmetic dentistry. The company provides its services to clients through its professional and specialized medical staff in therapeutic and cosmetic dentistry.
21GF Score

Get the complete analysis for SAU:9626

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼6.12
Price